NOX1 and colon carcinoma: Interestingly, in an experimental colon carcinoma model, treatment with a NOX1 inhibitor (GKT771) in combination with an anti-PD1 immune checkpoint inhibitor had an additional inhibitory effect on tumor growth, which suggest a possible therapeutic capacity of combining NOX1 inhibitors in other solid tumors such as HCC [31].